Reliv' International, Inc. Appoints Carl W. Hastings as Chief Scientific Officer
January 07, 2019 at 10:11 pm
Share
On January 1, 2019 (the "Closing Date"), Reliv' International, Inc. entered into, and completed, a Purchase Agreement ("Purchase Agreement") and associated agreements with Nutracom, LLC, pursuant to which Nutracom purchased the following assets used in the contract manufacturing operations of Reliv' International, Inc. (the "Business"). On the Closing Date, Reliv' International, Inc. entered into an employment agreement with Carl W. Hastings to serve as the Chief Scientific Officer. In such role Dr. Hastings will continue in the research and development of the Reliv' International, Inc.'s products and attend select company events.
Reliv' International, Inc. is a developer and marketer of a line of nutritional supplements addressing basic nutrition, specific wellness needs, weight management and sports nutrition. The Company sells its products through an international network marketing system using independent distributors. The Company operates through a network marketing segment consisting of six operating units that sell nutritional and dietary products to a sales force of independent distributors that sell the products directly to customers. Its products include Reliv Now with Soy; FibRestore; Innergize! Go; LunaRich; ReversAge; Reliv Now for Kids; Arthaffect; ProVantage; SoySentials; CardioSentials; Reliv Defense; RLV Hemp Full Spectrum 750, and others. Its geographic region includes the United States, Australia/New Zealand, Canada, Mexico, Europe and Asia. Its subsidiaries include Reliv, Inc., Reliv World Corporation, Reliv Australia Pty, Limited, Reliv Now de Mexico, S. de R.L. de C.V. and others.